Effects of high blood flow and high pre-dilution replacement fluid rates on small solute clearances in hemofiltration

Blood Purification

Volumn 32, Issue 4, 2011, Pages 266-270

  Gashti, Casey N ^a   Rodby, Roger A ^a   Huang, Zhongping ^b   Gao, Dayong ^c   Zhang, Weiming ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b WIDENER UNIVERSITY   (United States)

^c University of Washington   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Clearance; Hemofiltration; Pre dilution

Indexed keywords

CREATININE; UREA;

ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; FLUID FLOW; HEMOFILTRATION; PRIORITY JOURNAL; REPLACEMENT FLUID FLOW; ULTRAFILTRATION;

CREATININE; HEMOFILTRATION; HUMANS; KINETICS; RENAL BLOOD FLOW, EFFECTIVE; UREA;

EID: 80051943394     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000328740     Document Type: Article

References (13)

1. Gashti CN, Salcedo S, Robinson V, Rodby RA: Accelerated venovenous hemofiltration: early technical and clinical experience. Am J Kidney Dis 2008; 51: 804-810. (Pubitemid 351626249)
2. Cheung AK, Alford MF, Wilson MM, Leypoldt JK, Henderson LW: Urea movement across erythrocyte membrane during artificial kidney treatment. Kidney Int 1983; 23: 866-869. (Pubitemid 13067056)
3. Huang Z, Letteri JJ, Clark WR, Zhang W, Gao D, Ronco C: Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration. Int J Artif Organs 2007; 30: 124-132. (Pubitemid 46563987)
4. Scott MK, Mueller BA, Sowinski KM, Clark WR: Dialyzer-dependent changes in solute and water permeability with bleach reprocessing. Am J Kidney Dis 1999; 33: 87-96. (Pubitemid 29031213)
5. Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, LeBlanc M: Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 2003; 18: 961-966. (Pubitemid 36592540)
6. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999; 34: 486-492. (Pubitemid 29413621)
7. Humes DH, Ding F, Song JH: Dialysis dosing in critically ill patients with acute kidney injury. Am J Kidney Dis 2008; 52: 649-652.
8. Venkataraman R, Kellum J, Palevsky P: Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 2002; 17: 246-250. (Pubitemid 35447400)
9. Kellum J, Ronco C: Dialysis: Results of RENAL - what is the optimal CRRT target dose? Nat Rev Nephrol 2010; 6: 191-292.
10. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 2003; 94:C94-C98.
11. Van der Voort PH, Gerritsen RT, Kuiper MA, Egbers PH, Kingma WP, Boerma EC: Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparinprotamine anticoagulation. Blood Purif 2005; 23: 175-180. (Pubitemid 40874895)
12. Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB: Continuous venovenous hemofiltration with or without predilation regional citrate anticoagulation: a prospective study. Blood Purif 2007; 25: 316-323. (Pubitemid 47450565)
13. Oudemans-van Straaten KM: Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Blood Purif 2010; 29: 191-196.